-+ 0.00%
-+ 0.00%
-+ 0.00%

NEXGEL Expands Partnership With STADA To Launch New Digestive And Skin Care Products, Receives $1M Non-Dilutive Funding

Benzinga·07/14/2025 13:04:39
Listen to the news

NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced expanding its partnership with STADA Arzneimittel AG ("STADA"), a European leader in consumer health. The expansion includes the planned launch of digestive enzyme formulas and solutions targeting scars and stretch marks.

As part of the agreement, STADA will advance $1 million to NEXGEL in non-dilutive capital to support product launches and marketing efforts.